Industry Briefs: May 21, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Briefs: May 21, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.


Company News

Avalanche Biotechnologies and Lonza have formed a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral vectors for gene therapy. Read More

GlaxoSmithKline has completed the transaction to increase its ownership in the biopharmaceutical company Theravance. Read More

Lubrizol has formed LifeScience Polymers, a new product line created for the delivery of polymer technologies and solutions to the pharmaceutical and healthcare markets.

Marina Biotech and Girindus Group have formed a development, supply, and commercialization pact for oligonucleotide constructs. Read More

Mitsubishi Tanabe has announced plans to transfer its fine-chemical operations to two companies and withdraw from the fine-chemical industry. Read More

Piramal Healthcare has agreed to acquire Decision Resources Group, a healthcare information management company, for approximately $635 million. Read More

Shimadzu has added a triple quadrupole gas chromatograph mass spectrometer and has also expanded its LC–MS/MS product portfolio. Read More

People News

AMRI has appointed Ian Shott as president of AMRI Europe. Read More

BASi has named David Reynolds as its director of discovery systems. Read More

Camargo has appointed K. Gary Barnette as vice-president of drug development. Read More

Teva’s board of directors has voted to re-elect Phillip Frost as chairman of the board. Read More

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here